4 About the Compound Dihexa is a small synthetic oligopeptide derived from the three N-terminal residues of angiotensin IV (Nle-Tyr-Ile), with structural modifications that block enzymatic degradation, increase lipophilicity, and confer oral bioavailability and blood-brain barrier permeability
Deutsch SI, Urbano MR, Neumann SA, Burket JA, Katz E (2010) Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions
Kennedy has vowed to end "FDA's war" on peptides and other alternative treatments that are embraced by many in his Make America Healthy Again movement
Di Minno MND, Pezzullo S, Palmieri V, Coppola A, DAngelo A, Sampietro F, Cavalca V, Tremoli E, Di Minno G (2011) Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis